These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7804951)
1. Reducing the incidence of coronary heart disease by managing hypertension: implications of syndrome X. Reddy SS Can J Public Health; 1994; 85 Suppl 2():S51-3. PubMed ID: 7804951 [TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome X: a review. Timar O; Sestier F; Levy E Can J Cardiol; 2000 Jun; 16(6):779-89. PubMed ID: 10863169 [TBL] [Abstract][Full Text] [Related]
3. Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. Coughlan BJ; Sorrentino MJ Postgrad Med; 2000 Dec; 108(7):77-84. PubMed ID: 11126144 [TBL] [Abstract][Full Text] [Related]
4. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data]. Valensi P Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099 [TBL] [Abstract][Full Text] [Related]
5. Risk factor clusters for metabolic syndrome in coronary heart disease: state of the science. Saylor J Dimens Crit Care Nurs; 2005; 24(2):64-9. PubMed ID: 15827427 [TBL] [Abstract][Full Text] [Related]
6. Hypertension: a new perspective in therapy and metabolic effect. Part I. Medina Ruiz A Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274 [TBL] [Abstract][Full Text] [Related]
7. Effects of exercise on insulin resistance syndrome. Shahid SK; Schneider SH Coron Artery Dis; 2000 Mar; 11(2):103-9. PubMed ID: 10758810 [No Abstract] [Full Text] [Related]
13. Metabolic and cardiovascular characteristics of hypertension. Familial aspects. Neutel JM; Smith DH Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017 [TBL] [Abstract][Full Text] [Related]
14. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Wilcox I; McNamara SG; Collins FL; Grunstein RR; Sullivan CE Thorax; 1998 Oct; 53 Suppl 3(Suppl 3):S25-8. PubMed ID: 10193357 [No Abstract] [Full Text] [Related]
15. [Abdominal obesity and coronary heart disease. Pathophysiology and clinical significance]. Hauner H Herz; 1995 Feb; 20(1):47-55. PubMed ID: 7713476 [TBL] [Abstract][Full Text] [Related]
16. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. Yokoyama I; Yonekura K; Ohtake T; Yang W; Shin WS; Yamada N; Ohtomo K; Nagai R J Nucl Med; 2000 Jun; 41(6):978-85. PubMed ID: 10855621 [TBL] [Abstract][Full Text] [Related]
17. Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome. Dell'Omo G; Penno G; Pucci L; Mariani M; Del Prato S; Pedrinelli R Atherosclerosis; 2004 Feb; 172(2):383-9. PubMed ID: 15019550 [TBL] [Abstract][Full Text] [Related]
18. White blood cell count and insulin resistance in healthy nonsmoking men. Jeppesen JL; Maheux P; Facchini FS Am Heart J; 1994 Feb; 127(2):459-61. PubMed ID: 8296722 [No Abstract] [Full Text] [Related]
19. [A case of syndrome X whose hyperglycemia, hyperlipidemia and hypertension were improved as accompanying with decreased insulin resistance]. Hiramatsu S; Mimura K; Ono Y; Taniguchi S; Iwashige K; Umeda F; Nawata H Fukuoka Igaku Zasshi; 1994 Nov; 85(11):326-8. PubMed ID: 7851834 [TBL] [Abstract][Full Text] [Related]
20. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Shirai K Curr Med Res Opin; 2004 Mar; 20(3):295-304. PubMed ID: 15025838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]